This trial is testing a botanical agent called Anti-tumor B to see if it can shrink tumors. The study is comparing it to a placebo (fake treatment) to see if it is effective.
- Squamous Cell Carcinoma of the Mouth
1 Primary · 0 Secondary · Reporting Duration: Baseline and following surgery (seven to 28 days after baseline)
2 Treatment Groups
1 of 2
1 of 2
28 Total Participants · 2 Treatment Groups
Primary Treatment: Anti-tumor B · Has Placebo Group · Phase < 1
Who is running the clinical trial?
Age 18+ · All Participants · 11 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this research endeavor actively enrolling participants?
"Affirmative. Clinicaltrials.gov has information that suggests this medical study is now recruiting people interested in participating. The trial was introduced on April 22nd 2022, and a recent update to the posting occurred on the same date. 28 participants need to be recruited from just one centre for the trial's completion." - Anonymous Online Contributor
How many participants are being investigated as part of this research endeavor?
"Affirmative. The information on clinicaltrials.gov attests that this scientific research project, initially posted April 22nd 2022 is presently recruiting patients. Twenty-eight participants are required across a single center." - Anonymous Online Contributor